Bristol-Myers Inks $10M Deal To End Drug Antitrust Claims
By Nadia Dreid · November 5, 2021, 9:59 PM EDT
Bristol-Myers Squibb has reached a $10 million settlement to escape claims that it conspired with rivals to keep a blockbuster HIV treatment off the market, and both sides are hoping that...
To view the full article, register now.